{"id":"loxoprofen","rwe":[{"pmid":"41890201","year":"2026","title":"Integrated multi-omics elucidates the dual anti-inflammatory and neuroendocrine mechanisms of novel TCM plasters against primary dysmenorrhea.","finding":"","journal":"Frontiers in pain research (Lausanne, Switzerland)","studyType":"Clinical Study"},{"pmid":"41882895","year":"2026","title":"Anaphylaxis and Fulminant Disseminated Intravascular Coagulation Due to Loxoprofen.","finding":"","journal":"Internal medicine (Tokyo, Japan)","studyType":"Clinical Study"},{"pmid":"41874059","year":"2026","title":"Assessment of Potential Exposure to Pregnancy-Contraindicated Medications Among Women of Reproductive Age in Japan: A Retrospective Database Study.","finding":"","journal":"Pharmacy (Basel, Switzerland)","studyType":"Clinical Study"},{"pmid":"41857663","year":"2026","title":"Comprehension of medication-related information translated from Japanese to Southeast Asian Languages using google translate.","finding":"","journal":"Journal of pharmaceutical health care and sciences","studyType":"Clinical Study"},{"pmid":"41729853","year":"2026","title":"Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study.","finding":"","journal":"PloS one","studyType":"Clinical Study"}],"tags":[{"label":"loxoprofen","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Prostaglandin G/H synthase 1","category":"target"},{"label":"PTGS1","category":"gene"},{"label":"PTGS2","category":"gene"},{"label":"M02AA31","category":"atc"},{"label":"Active","category":"status"},{"label":"Rheumatoid arthritis","category":"indication"},{"label":"Lead Chemical Co., Ltd.","category":"company"},{"label":"Analgesics","category":"pharmacology"},{"label":"Analgesics, Non-Narcotic","category":"pharmacology"},{"label":"Anti-Inflammatory Agents","category":"pharmacology"},{"label":"Anti-Inflammatory Agents, Non-Steroidal","category":"pharmacology"},{"label":"Antirheumatic Agents","category":"pharmacology"},{"label":"Peripheral Nervous System Agents","category":"pharmacology"},{"label":"Sensory System Agents","category":"pharmacology"}],"phase":"marketed","safety":{"safetySignals":[{"llr":798.605,"date":"","count":462,"signal":"Interstitial lung disease","source":"DrugCentral FAERS","actionTaken":"Reported 462 times (LLR=799)"},{"llr":553.093,"date":"","count":463,"signal":"Platelet count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 463 times (LLR=553)"},{"llr":460.258,"date":"","count":275,"signal":"Hepatic function abnormal","source":"DrugCentral FAERS","actionTaken":"Reported 275 times (LLR=460)"},{"llr":411.486,"date":"","count":341,"signal":"Malignant neoplasm progression","source":"DrugCentral FAERS","actionTaken":"Reported 341 times (LLR=411)"},{"llr":263.69,"date":"","count":217,"signal":"Neutrophil count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 217 times (LLR=264)"},{"llr":259.552,"date":"","count":303,"signal":"White blood cell count decreased","source":"DrugCentral FAERS","actionTaken":"Reported 303 times (LLR=260)"},{"llr":197.134,"date":"","count":42,"signal":"Fatigue","source":"DrugCentral FAERS","actionTaken":"Reported 42 times (LLR=197)"},{"llr":195.52,"date":"","count":75,"signal":"Drug ineffective","source":"DrugCentral FAERS","actionTaken":"Reported 75 times (LLR=196)"},{"llr":193.465,"date":"","count":135,"signal":"Osteonecrosis of jaw","source":"DrugCentral FAERS","actionTaken":"Reported 135 times (LLR=193)"},{"llr":172.126,"date":"","count":400,"signal":"Anaemia","source":"DrugCentral FAERS","actionTaken":"Reported 400 times (LLR=172)"},{"llr":166.647,"date":"","count":343,"signal":"Decreased appetite","source":"DrugCentral FAERS","actionTaken":"Reported 343 times (LLR=167)"},{"llr":166.185,"date":"","count":112,"signal":"Disseminated intravascular coagulation","source":"DrugCentral FAERS","actionTaken":"Reported 112 times (LLR=166)"},{"llr":163.091,"date":"","count":119,"signal":"Drug eruption","source":"DrugCentral FAERS","actionTaken":"Reported 119 times (LLR=163)"},{"llr":141.49,"date":"","count":141,"signal":"Liver disorder","source":"DrugCentral FAERS","actionTaken":"Reported 141 times (LLR=141)"},{"llr":122.132,"date":"","count":463,"signal":"Pyrexia","source":"DrugCentral FAERS","actionTaken":"Reported 463 times (LLR=122)"}],"commonSideEffects":[]},"trials":[],"aliases":[],"company":"Lead Chemical Co., Ltd.","patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=LOXOPROFEN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:20:28.718250+00:00"},"timeline":{"url":"https://en.wikipedia.org/wiki/Loxoprofen","method":"deterministic","source":"Wikipedia","rawText":"","confidence":0.8,"sourceType":"wikipedia","retrievedAt":"2026-04-20T01:20:35.436714+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:20:34.003100+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LOXOPROFEN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:20:34.384908+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Cyclooxygenase inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:20:35.436644+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL19299/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:20:35.088781+00:00"}},"allNames":"loxonin","offLabel":[],"synonyms":["loxoprofen sodium hydrate","loxonin","loxoprofen","loxoprofen sodium","sodium loxoprofen"],"timeline":[{"date":"2006-01-23","type":"positive","source":"DrugCentral","milestone":"PMDA approval (Lead Chemical Co., Ltd.)"}],"approvals":[{"date":"2006-01-23","orphan":false,"company":"Lead Chemical Co., Ltd.","regulator":"PMDA"}],"brandName":"Loxonin","ecosystem":[{"indication":"Rheumatoid arthritis","otherDrugs":[{"name":"abatacept","slug":"abatacept","company":"Bristol Myers Squibb"},{"name":"aceclofenac","slug":"aceclofenac","company":""},{"name":"acetylsalicylic acid","slug":"acetylsalicylic-acid","company":"Endo Pharms"},{"name":"adalimumab","slug":"adalimumab","company":"Abbvie Inc"}],"globalPrevalence":18000000}],"mechanism":{"target":"Prostaglandin G/H synthase 1","targets":[{"gene":"PTGS1","source":"DrugCentral","target":"Prostaglandin G/H synthase 1","protein":"Prostaglandin G/H synthase 1"},{"gene":"PTGS2","source":"DrugCentral","target":"Prostaglandin G/H synthase 2","protein":"Prostaglandin G/H synthase 2"}],"modality":"Small Molecule","drugClass":"loxoprofen","explanation":"","oneSentence":"","technicalDetail":"Loxonin acts as a non-selective inhibitor of cyclooxygenase (COX) enzymes, specifically COX-1, which is responsible for the production of prostaglandins from arachidonic acid."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Loxoprofen","title":"Loxoprofen","extract":"Loxoprofen is a nonsteroidal anti-inflammatory drug (NSAID) in the propionic acid derivatives group, which also includes ibuprofen and naproxen among others. It is available in some countries for oral administration. A transdermal preparation was approved for sale in Japan in January 2006; medicated tape and gel formulations followed in 2008 and 2010."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1615","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=LOXOPROFEN","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=LOXOPROFEN","fields":["publications"],"source":"PubMed/NCBI"},{"id":4,"url":"https://en.wikipedia.org/wiki/Loxoprofen","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T12:25:40.947613","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:20:36.744483+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"phenylbutazone","drugSlug":"phenylbutazone","fdaApproval":"1980-01-10","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"oxyphenbutazone","drugSlug":"oxyphenbutazone","fdaApproval":"1960-12-21","genericCount":1,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"piroxicam","drugSlug":"piroxicam","fdaApproval":"1982-04-06","genericCount":18,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ketoprofen","drugSlug":"ketoprofen","fdaApproval":"1986-01-09","genericCount":7,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"naproxen","drugSlug":"naproxen","fdaApproval":"1976-03-11","genericCount":31,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"ibuprofen","drugSlug":"ibuprofen","fdaApproval":"1974-09-19","patentExpiry":"Sep 30, 2029","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"diclofenac","drugSlug":"diclofenac","fdaApproval":"1988-07-28","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"meclofenamic acid","drugSlug":"meclofenamic-acid","fdaApproval":"1980-06-25","relationship":"same-class"},{"drugName":"flurbiprofen","drugSlug":"flurbiprofen","fdaApproval":"1986-12-31","genericCount":8,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"tolmetin","drugSlug":"tolmetin","fdaApproval":"1976-03-24","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-class"},{"drugName":"indomethacin","drugSlug":"indomethacin","fdaApproval":"1965-06-10","patentExpiry":"Apr 23, 2030","patentStatus":"Patent protected","relationship":"same-class"},{"drugName":"aceclofenac","drugSlug":"aceclofenac","fdaApproval":"","relationship":"same-class"}],"genericName":"loxoprofen","indications":{"approved":[{"name":"Rheumatoid arthritis","source":"DrugCentral","snomedId":69896004,"regulator":"FDA","usPrevalence":1500000,"globalPrevalence":18000000,"prevalenceMethod":"curated","prevalenceSource":"Lancet Rheumatology, 2023"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"phenylbutazone","brandName":"phenylbutazone","genericName":"phenylbutazone","approvalYear":"1980","relationship":"same-class"},{"drugId":"oxyphenbutazone","brandName":"oxyphenbutazone","genericName":"oxyphenbutazone","approvalYear":"1960","relationship":"same-class"},{"drugId":"piroxicam","brandName":"piroxicam","genericName":"piroxicam","approvalYear":"1982","relationship":"same-class"},{"drugId":"ketoprofen","brandName":"ketoprofen","genericName":"ketoprofen","approvalYear":"1986","relationship":"same-class"},{"drugId":"naproxen","brandName":"naproxen","genericName":"naproxen","approvalYear":"1976","relationship":"same-class"},{"drugId":"ibuprofen","brandName":"ibuprofen","genericName":"ibuprofen","approvalYear":"1974","relationship":"same-class"},{"drugId":"diclofenac","brandName":"diclofenac","genericName":"diclofenac","approvalYear":"1988","relationship":"same-class"},{"drugId":"meclofenamic-acid","brandName":"meclofenamic acid","genericName":"meclofenamic acid","approvalYear":"1980","relationship":"same-class"},{"drugId":"flurbiprofen","brandName":"flurbiprofen","genericName":"flurbiprofen","approvalYear":"1986","relationship":"same-class"},{"drugId":"tolmetin","brandName":"tolmetin","genericName":"tolmetin","approvalYear":"1976","relationship":"same-class"}],"trialDetails":[{"nctId":"NCT07391501","phase":"PHASE4","title":"Nitroglycerin Ointment for Pain Relief After Endoscopic Hemorrhoid Band Ligation","status":"NOT_YET_RECRUITING","sponsor":"Ying Zhu","startDate":"2026-02-01","conditions":["Internal Hemorrhoids","Postoperative Pain After Endoscopic Rubber Band Ligation"],"enrollment":68,"completionDate":"2028-11-30"},{"nctId":"NCT07378059","phase":"NA","title":"The Analgesic Efficacy and Safety of Loxoprofen Sodium Patch in Patients With Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":["Herpes Zoster","Pain"],"enrollment":750,"completionDate":"2027-12-31"},{"nctId":"NCT06785350","phase":"NA","title":"Minimum Effective Dose of Incisional Local Infiltration Betamethasone for the Prevention of Pain After Spinal Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-01-25","conditions":["Pain Management","Spine Surgery"],"enrollment":535,"completionDate":"2025-12-01"},{"nctId":"NCT06967363","phase":"","title":"Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-15","conditions":["Chronic Low Back Pain (CLBP)","Acute Low Back Pain","Low Back Pain","Chronic Pain","Acute Pain","Mental Disorders","Sleep Disorder","Fibromyalgia (FM)","Nociplastic Pain","Neuropathic Pain","Nonspecific Low Back Pain"],"enrollment":360,"completionDate":"2028-12-31"},{"nctId":"NCT06510413","phase":"PHASE1","title":"An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers","status":"NOT_YET_RECRUITING","sponsor":"Frontier Biotechnologies Inc.","startDate":"2024-07","conditions":["Osteoarthritis","Muscle Pain","Swelling Muscle"],"enrollment":40,"completionDate":"2024-08"},{"nctId":"NCT06047483","phase":"PHASE2","title":"A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis","status":"UNKNOWN","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2023-10","conditions":["Analgesia and Anti-inflammatory of Osteoarthritis"],"enrollment":90,"completionDate":"2023-12"},{"nctId":"NCT02384928","phase":"NA","title":"Effects of Shinbaro Pharmacopuncture in Sciatic Pain Patients With Lumbar Disc Herniation","status":"COMPLETED","sponsor":"Jaseng Medical Foundation","startDate":"2015-09-09","conditions":["Sciatica","Intervertebral Disc Displacement"],"enrollment":60,"completionDate":"2017-03-16"},{"nctId":"NCT02983747","phase":"NA","title":"Autologous Platelet Rich Plasma on Low Back Pain","status":"UNKNOWN","sponsor":"Shanghai Changzheng Hospital","startDate":"2019-11-01","conditions":["Low Back Pain"],"enrollment":112,"completionDate":"2022-12-30"},{"nctId":"NCT04386122","phase":"PHASE1","title":"An in Vivo Bioequivalence Study of 2 Loxoprofen Sodium Products in Vietnamese Healthy Male Volunteers","status":"COMPLETED","sponsor":"Centre of Clinical Pharmacology, Hanoi Medical University","startDate":"2020-05-07","conditions":["Bioequivalence"],"enrollment":24,"completionDate":"2020-05-31"},{"nctId":"NCT00141154","phase":"PHASE3","title":"Comparison Of Celecoxib 200 Mg Bid, Loxoprofen Sodium 60 Mg Tid And Placebo In Low Back Pain In Japan","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-10","conditions":["Low Back Pain"],"enrollment":1234,"completionDate":""},{"nctId":"NCT00994461","phase":"PHASE4","title":"Study Of Celecoxib In Healthy Subjects","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2009-11","conditions":["Healthy Volunteers"],"enrollment":190,"completionDate":"2010-04"},{"nctId":"NCT04611685","phase":"NA","title":"Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas","status":"UNKNOWN","sponsor":"Peking Union Medical College Hospital","startDate":"2020-10-31","conditions":["Pituitary Adenoma","Surgery","Pain"],"enrollment":202,"completionDate":"2021-10"},{"nctId":"NCT03386149","phase":"PHASE3","title":"Clinical Research on the Efficacy of Bosinji on Herniated Intervertebral Disc of Lumbar Spine","status":"COMPLETED","sponsor":"Kyunghee University Medical Center","startDate":"2017-12-28","conditions":["Lumbar Disc Herniation"],"enrollment":74,"completionDate":"2020-01-22"},{"nctId":"NCT02467504","phase":"PHASE2","title":"Low-dose Recombinant Human IL-2 for the Treatment of Rheumatoid Arthritis","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2015-07-01","conditions":["Rheumatoid Arthritis"],"enrollment":47,"completionDate":"2017-08-31"},{"nctId":"NCT03800797","phase":"PHASE4","title":"Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2015-05-25","conditions":["Ankylosing Spondylitis"],"enrollment":70,"completionDate":"2015-12-10"},{"nctId":"NCT02831569","phase":"PHASE3","title":"Japanese IP-TN Trial","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2016-07-27","conditions":["Pain"],"enrollment":80,"completionDate":"2016-10-19"},{"nctId":"NCT02616068","phase":"PHASE3","title":"Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma","status":"COMPLETED","sponsor":"Daiichi Sankyo Brasil Farmacêutica LTDA","startDate":"2015-10","conditions":["Trauma","Pain"],"enrollment":242,"completionDate":"2016-12"},{"nctId":"NCT02602353","phase":"PHASE2","title":"Pilot Study Comparing the Efficacy and Safety of a New Pain Patch and Placebo in Delayed Onset Muscle Soreness (DOMS)","status":"COMPLETED","sponsor":"Lead Chemical Co., Ltd.","startDate":"2015-10","conditions":["Delayed Onset Muscle Soreness"],"enrollment":42,"completionDate":"2015-12"},{"nctId":"NCT01779271","phase":"PHASE3","title":"Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2013-01","conditions":["Acute Upper Respiratory Infection","Fever"],"enrollment":183,"completionDate":""},{"nctId":"NCT01922466","phase":"PHASE2","title":"East-West Collaboration Treatment Using Bee Venom Acupuncture and NSAIDs for Chronic Cervicalgia","status":"COMPLETED","sponsor":"Kyunghee University Medical Center","startDate":"2013-07","conditions":["Chronic Non-specific, Uncomplicated Neck Pain"],"enrollment":60,"completionDate":"2014-07"},{"nctId":"NCT01491321","phase":"PHASE2","title":"Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain","status":"UNKNOWN","sponsor":"Kyunghee University Medical Center","startDate":"2011-04","conditions":["Chronic Low Back Pain"],"enrollment":54,"completionDate":"2012-03"},{"nctId":"NCT00676117","phase":"PHASE1","title":"Drug-Drug Interaction Study of Esomeprazole (D961H) Capsule and Loxoprofen Tablet After Repeated Oral Administration in Japanese Males","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2008-04","conditions":["Healthy"],"enrollment":30,"completionDate":"2008-07"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"008162","UNII":"3583H0GZAP","CHEBI":"CHEBI:31786","INN_ID":"5410","RXNORM":"28908","UMLSCUI":"C0065199","chemblId":"CHEMBL19299","ChEMBL_ID":"CHEMBL19299","KEGG_DRUG":"D08149","DRUGBANK_ID":"DB09212","PUBCHEM_CID":"3965","SNOMEDCT_US":"18991000122102","SECONDARY_CAS_RN":"80382-23-6","MESH_SUPPLEMENTAL_RECORD_UI":"C040656"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[{"period":"present","companyName":"Lead Chemical Co., Ltd.","relationship":"Current Owner"}],"publicationCount":433,"therapeuticAreas":["Immunology"],"atcClassification":{"source":"DrugCentral","atcCode":"M02AA31","allCodes":["M02AA31"]},"biosimilarFilings":[],"recentPublications":[{"date":"2026","pmid":"41890201","title":"Integrated multi-omics elucidates the dual anti-inflammatory and neuroendocrine mechanisms of novel TCM plasters against primary dysmenorrhea.","journal":"Frontiers in pain research (Lausanne, Switzerland)"},{"date":"2026 Mar 24","pmid":"41882895","title":"Anaphylaxis and Fulminant Disseminated Intravascular Coagulation Due to Loxoprofen.","journal":"Internal medicine (Tokyo, Japan)"},{"date":"2026 Mar 20","pmid":"41874059","title":"Assessment of Potential Exposure to Pregnancy-Contraindicated Medications Among Women of Reproductive Age in Japan: A Retrospective Database Study.","journal":"Pharmacy (Basel, Switzerland)"},{"date":"2026 Mar 19","pmid":"41857663","title":"Comprehension of medication-related information translated from Japanese to Southeast Asian Languages using google translate.","journal":"Journal of pharmaceutical health care and sciences"},{"date":"2026","pmid":"41729853","title":"Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study.","journal":"PloS one"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","companyName":"Lead Chemical Co., Ltd.","companyId":"lead-chemical-co-ltd","modality":"Small molecule","firstApprovalDate":"1986","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"JP","regulator":"PMDA","status":"approved","approval_date":"2006-01-23T00:00:00.000Z","mah":"Lead Chemical Co., Ltd.","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:20:36.744483+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}